Sign In
Buy VIR
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
02:58pm, Tuesday, 19'th Mar 2024
Given the current risk-on sentiment, it is perhaps an ideal time for investors to scoop up some of the top biotech stocks. The stock market is booming, and with investors looking to take on more risk
Billionaire's Biotech Bets: 3 Stocks Dominating Bill Gates' Portfolio
11:07am, Wednesday, 13'th Mar 2024
Since Bill Gates left his position with Microsoft (NASDAQ: MSFT ) he diversified his stock portfolio away from the tech giant. Instead, biotechnology has been is primary interest.
Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
11:56pm, Tuesday, 27'th Feb 2024
Vir Biotechnology is developing treatments for Hepatitis B, Hepatitis Delta, HIV, and COVID, among others.
3 Highly Rated Biotech Stocks to Buy for 300% Gains
06:55am, Monday, 26'th Feb 2024
Investors know that the world of biotech stocks is home to a great percentage of opportunities that can triple and quadruple their capital. It's also fairly easy to identify such stocks using screener
Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade
10:56am, Friday, 23'rd Feb 2024
The consensus price target hints at an 186.4% upside potential for Vir Biotechnology, Inc. (VIR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in e
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
08:05am, Friday, 23'rd Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)---- $VIR--Vir Biotechnology to participate in upcoming March investor healthcare conferences.
Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings Call Transcript
08:48pm, Thursday, 22'nd Feb 2024
Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings Call Transcript
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
06:51pm, Thursday, 22'nd Feb 2024
Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to loss of $0.76 per share a year ago.
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Thursday, 22'nd Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023. “
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
04:05pm, Thursday, 01'st Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)---- $VIR--Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024.
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
01:16pm, Wednesday, 31'st Jan 2024
GSK's revenues benefit from strong growth across all segments, especially the Shingles and RSV vaccines. The company also issues fresh 2024 guidance for all its segments.
Vir Biotechnology (VIR) Gains 21.7% in 3 Months: Here's Why
12:47pm, Monday, 15'th Jan 2024
After a major pipeline setback, Vir Biotechnology (VIR) stock gains 21.7% in three months on its restructuring plan to cut operating expenses.
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
04:05pm, Wednesday, 06'th Dec 2023
SAN FRANCISCO--(BUSINESS WIRE)---- $VIR #JPM2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Vir's Chief Executive Officer, will present at the J
7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
06:10am, Thursday, 30'th Nov 2023
Small-cap stocks to buy offer a window into the future of the global economy, encapsulating companies with market capitalizations upwards of $250 million and $2.5 billion. These are the potential gian
From laggards to leaders: Small caps on the rise
08:45am, Monday, 27'th Nov 2023
Stocks driving that large-cap index performance include names you've become familiar with this year, such as Nvidia Corp. NASDAQ: NVDA, Tesla Inc. NASDAQ: TSLA and Meta Platforms Inc. NASDAQ: META, bu
